AU2002221905A1 - Mammalian nuclear receptor cofactor cf9 and methods of use - Google Patents
Mammalian nuclear receptor cofactor cf9 and methods of useInfo
- Publication number
- AU2002221905A1 AU2002221905A1 AU2002221905A AU2190502A AU2002221905A1 AU 2002221905 A1 AU2002221905 A1 AU 2002221905A1 AU 2002221905 A AU2002221905 A AU 2002221905A AU 2190502 A AU2190502 A AU 2190502A AU 2002221905 A1 AU2002221905 A1 AU 2002221905A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- nuclear receptor
- mammalian nuclear
- receptor cofactor
- cofactor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00126022 | 2000-11-28 | ||
EP00126022 | 2000-11-28 | ||
PCT/EP2001/013891 WO2002044365A1 (en) | 2000-11-28 | 2001-11-28 | Mammalian nuclear receptor cofactor cf9 and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002221905A1 true AU2002221905A1 (en) | 2002-06-11 |
Family
ID=8170516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002221905A Abandoned AU2002221905A1 (en) | 2000-11-28 | 2001-11-28 | Mammalian nuclear receptor cofactor cf9 and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002221905A1 (en) |
WO (1) | WO2002044365A1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1320616A (en) * | 2000-04-27 | 2001-11-07 | 上海博德基因开发有限公司 | Polypeptide-human Pax protein 17 and polynucleotide for coding it |
-
2001
- 2001-11-28 AU AU2002221905A patent/AU2002221905A1/en not_active Abandoned
- 2001-11-28 WO PCT/EP2001/013891 patent/WO2002044365A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002044365A1 (en) | 2002-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001244625A1 (en) | Cell culturing method and device | |
AU7524601A (en) | T cell receptor fusions and conjugates and methods of use thereof | |
AU1939801A (en) | In situ bioreactors and methods of use thereof | |
AU2001283228A1 (en) | Method of fabricating thermally stable mtj cell and apparatus | |
AU3510100A (en) | Active probe for an atomic force microscope and method of use thereof | |
AU2342000A (en) | Generation and detection of induced current using acoustic energy | |
AU2002225756A1 (en) | Uses of mammalian genes and related reagents | |
AU2002315168A1 (en) | Combination therapy of gamma-interferon and b cell specific antibodies | |
AU2001292617A1 (en) | Mammalian receptor genes and uses | |
AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
WO2001041823A8 (en) | Radioactive compositions and methods of use thereof | |
AU3873200A (en) | Mammalian cytokines; related reagents and methods | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
AU2002230459A1 (en) | Cell culture apparatus and methods of use | |
AU6162199A (en) | Reversibly immortalized hepatocytes and methods of use | |
AU2001270126A1 (en) | Image analysis for phenotyping sets of mutant cells | |
AU4014700A (en) | Tuberculosis antigens and methods of use therefor | |
AU2002248051A1 (en) | Stabilized biocatalysts and methods of bioconversion using the same | |
AU2002221905A1 (en) | Mammalian nuclear receptor cofactor cf9 and methods of use | |
AU2001236965A1 (en) | Method and system of user profile generation | |
AU2001217686A1 (en) | Method of establishing cultures of human dendritic cells and use thereof | |
AU2001261496A1 (en) | Luxo-sigma54 interactions and methods of use | |
AU2001267367A1 (en) | Method of incineration of minor actinides in nuclear reactors | |
AU2002230479A1 (en) | Cell culture apparatus and methods of use | |
AU2998300A (en) | Genetically altered mesenchymal stem cells and methods of use thereof |